BACKGROUND The clinical courses of patients with medullary thyroid carcinoma (MTC)
vary, and a number of prognostic factors have been studied, but the significance of some of …

BACKGROUND. Medullary thyroid cancer (MTC) is a rare cancer. There is a relative paucity
of data over the last decade with regard to the prognosis of these patients. Therefore, the …

BACKGROUND The prognostic significance of the histologic and clinical features of
medullary thyroid cancer (MTC) and their impact on therapy and outcome have been …

Medullary thyroid carcinoma (MTC) is a malignancy of the thyroid C-cells that comprises 5–
10% of all thyroid cancers. MTC occurs in both sporadic and familial forms, the latter making …

AIM: The analysis of a 37-year retrospective study on diagnosis, prognostic variables,
treatment and outcome of a large group of medullary thyroid cancer (MTC) patients was …

Aims The aims of this study were to assess the long-term results of treatment of medullary
thyroid carcinoma (MTC) and to define prognostic factors. Methods Retrospective analysis of …

BACKGROUND: The surgical management and follow-up strategy in patients with medullary
thyroid carcinoma (MTC) remain controversial because of the lack of data on the natural …

BACKGROUND: There have been significant improvements in the management of
medullary thyroid cancer (MTC), and consensus treatment guidelines have been …

BACKGROUND Prognostic factors of sporadic or inherited medullary thyroid carcinoma
(MTC) are still controversial and have been assessed in old and small series. A better …

Objective The clinical course of patients with medullary thyroid carcinoma (MTC) is variable,
even in the subgroup of patients after surgery with curative intent and postoperatively …